MDGL - Wolfe Research starts Akero at outperform cites MASH drug prospects June, 11 2024 01:49 PM Madrigal Pharmaceuticals Inc. 2024-06-11 13:49:24 ET More on Akero Therapeutics Akero Therapeutics' EFX Data Warrants Caution Seeking Alpha’s Quant Rating on Akero Therapeutics Historical earnings data for Akero Therapeutics Financial information for Akero Therapeutics For further details see: Wolfe Research starts Akero at outperform, cites MASH drug prospects